Flavio Roberto Takeda
Appearances
- DateMay 19, 2024BACKGROUND: The standard approach for the treatment of patients with locally advanced adenocarcinomas of the gastroesophageal junction (AGEJ) includes perioperative chemotherapy (CMT) or chemoradiation therapy (CRT)…
Presenter
Speakers
- DateMay 7, 2023BACKGROUND: Despite the advances in the multidisciplinary treatment of gastric adenocarcinoma, the overall 5-year survival remains only 33.3% in North America. R0 resection with adequate lymphadenectomy remains the mainstay therapy…
Presenter
Speakers
Sao Paulo UniversityUniversity of São Paulo - DateMay 18, 2024VESTIBULE-ENTERAL ANASTOMOSIS: A NOVEL SURGICAL TECHNIQUE FOR ESOPHAGEAL RECONSTRUCTION
Moderators
The University of Texas Medical Branch at GalvestonMount SinaiSpeakers
Helwan Universitycairo universityClinic Beau-Site Berne - DateMay 18, 2024Salvage esophagectomy after definitive chemoradiotherapy treatment has traditionally been recognized as a feasible option. Robotic esophagectomy has been considered as alternative to minimize post operative complications. The thoracic field was performed robotically…
Speakers
- DateMay 21, 2024SOCIETY: SSAT
Speaker
Moderators
MedStar Georgetown University HospitalDDW